Loading
An trial of Rocapuldencel-T run by Roswell Park Cancer Institute, terminated.
Vaccine Therapy Before Surgery in Treating Patients With Localized Kidney Cancer is an interventional study registered as NCT02170389 by Roswell Park Cancer Institute, with 5 participants enrolled, started 2014-10-14. Conditions recorded: Recurrent Renal Cell Carcinoma, Stage I Renal Cell Cancer and Stage II Renal Cell Cancer. Interventions recorded: Laboratory Biomarker Analysis, Nephrectomy and Renal Cell Carcinoma/CD40L RNA-Transfected Autologous Dendritic Cell Vaccine AGS-003.
Shares Rocapuldencel-T, Argos Therapeutics, Renal cell carcinoma and the tag pipeline.
Shares Rocapuldencel-T, Argos Therapeutics, Renal cell carcinoma and the tag pipeline.
Shares Rocapuldencel-T, Argos Therapeutics, Renal cell carcinoma and the tag pipeline.
Shares Rocapuldencel-T, Argos Therapeutics, Renal cell carcinoma and the tag pipeline.
Shares Rocapuldencel-T, Argos Therapeutics and the tag pipeline.
Shares Rocapuldencel-T, Argos Therapeutics and the tag pipeline.
Shares Renal cell carcinoma and the tag pipeline.
Shares Renal cell carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/